Talphera (TLPH) Amortizatization of Intangibles (2011 - 2023)
Talphera (TLPH) posted Amortizatization of Intangibles of $100000.0 for Q3 2023, little changed on a QoQ basis from $100000.0 in Q2 2023, and little changed year-over-year from $100000.0 in Q3 2022.
Powered by 
Analysis
Talphera (TLPH) Amortizatization of Intangibles (2011 - 2023) Analysis & Trends
Talphera has reported Amortizatization of Intangibles for 13 years, with the latest figure at $100000.0 in Q3 2023.
- On a quarterly basis, Amortizatization of Intangibles changed 0.0% year-over-year to $100000.0 in Q3 2023; TTM through Jun 2024 was $100000.0, a 66.44% decrease from a year earlier, with the FY2023 full-year figure at $53000.0, down 86.51% from the prior year.
- Amortizatization of Intangibles was $100000.0 for Q3 2023 at Talphera, roughly flat from $100000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $700000.0 in Q2 2022, with the low at $38000.0 in Q1 2023.
- Average Amortizatization of Intangibles over 5 years is $187631.6, with a median of $154000.0 recorded in 2021.
- The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles surged 250.0% in 2022, then plunged 85.71% in 2023.
- Over 5 years, Amortizatization of Intangibles stood at $241000.0 in 2019, then climbed by 2.07% to $246000.0 in 2020, then plunged by 37.4% to $154000.0 in 2021, then tumbled by 61.04% to $60000.0 in 2022, then surged by 66.67% to $100000.0 in 2023.
- The last three Amortizatization of Intangibles figures came in at $100000.0 (Q3 2023), $100000.0 (Q2 2023), and $38000.0 (Q1 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.58 Bn | 192.59 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.17 Bn | 176.99 Bn | 6.22 Bn | 600.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.59 Bn | 122.74 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.61 Bn | 73.61 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.24 Bn | 55.05 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.29 Bn | 49.15 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 32.96 Bn | 29.65 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.94 Bn | 30.66 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.38 Bn | 29.38 Bn | 1.16 Mn | 1.39 Mn |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 38,000.00 |
| Dec 31, 2022 | 60,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 700,000.00 |
| Mar 31, 2022 | 134,000.00 |
| Dec 31, 2021 | 154,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Jun 30, 2021 | 200,000.00 |
| Mar 31, 2021 | 222,000.00 |
| Dec 31, 2020 | 246,000.00 |
| Sep 30, 2020 | 200,000.00 |
| Jun 30, 2020 | 300,000.00 |
| Mar 31, 2020 | 271,000.00 |
| Dec 31, 2019 | 241,000.00 |
| Sep 30, 2019 | 200,000.00 |
| Jun 30, 2019 | 100,000.00 |
| Mar 31, 2019 | 99,000.00 |
| Dec 31, 2018 | 124,000.00 |